HDFC SILVER ETF FUND OF…₹38.974.29% TATA SILVER ETF FUND OF…₹30.924.27% DSP SILVER ETF₹24.524.18% NIPPON INDIA SILVER ETF₹35.924.16% UTI SILVER ETF₹30.164.15% MIRAE ASSET SILVER ETF₹10.514.11% SBI SILVER ETF₹25.144.07% ZERODHA SILVER ETF₹21.504.05% ADITYA BIRLA SUN LIFE S…₹36.604.03% GROWW SILVER ETF₹22.873.98% HDFC SILVER ETF FUND OF…₹38.974.29% TATA SILVER ETF FUND OF…₹30.924.27% DSP SILVER ETF₹24.524.18% NIPPON INDIA SILVER ETF₹35.924.16% UTI SILVER ETF₹30.164.15% MIRAE ASSET SILVER ETF₹10.514.11% SBI SILVER ETF₹25.144.07% ZERODHA SILVER ETF₹21.504.05% ADITYA BIRLA SUN LIFE S…₹36.604.03% GROWW SILVER ETF₹22.873.98%
GFS GFSGayatri Financial Synergy
/
Client Login
GFS » Mutual Fund » Sectoral / Thematic » Nippon India Pharma Fund
Published NAVNAV published by the AMC, sourced from AMFI
91.93287.57483.22678.861 Aug 201620 Aug 2026
Change+343.1%change over the window — not annualised
Low / high₹123.37 / ₹647.4225 May 2017 · 11 Aug 2026
Last print+0.12%19 Aug 2026 → 20 Aug 2026
Prints1,119published NAVs, AMFI · axis does not start at zero

Returns

NAV and returns as at 20 Aug 2026
Lumpsum · point to point
1W -0.56%
1M +0.48%
3M +4.2%
6M +13.35%
YTD +12.78%
1Y +10.93%
2Y CAGR +7.68%
3Y CAGR +18.89%
5Y CAGR +14.5%
10Y CAGR +16.06%
SIP · XIRR on monthly instalments
6M SIP +33.41%
1Y SIP +20.04%
2Y SIP +12.23%
3Y SIP +14.71%
5Y SIP +18.07%
10Y SIP +19%
Full history SIP +19%
Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68% have a 3-year figure, 48.8% a 5-year one, and 32.7% a 10-year one.

Returns vs category

1Y
This fund
+10.93%
Sectoral / Thematic avg
+9.11%
3Y
This fund
+18.89%
Sectoral / Thematic avg
+17.01%
5Y
This fund
+14.5%
Sectoral / Thematic avg
+14.93%
Average is the mean of every Sectoral/ Thematic scheme in this dataset that discloses the period — 216 schemes at 1Y, 126 at 3Y, 94 at 5Y. Returns beyond one year are annualised.

Top holdings

as at 31 Jul 2026 · source: AMC monthly portfolio disclosure
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology 13.31%
Lupin LimitedPharmaceuticals & Biotechnology 7.25%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology 6.52%
Cipla LimitedPharmaceuticals & Biotechnology 6.03%
Apollo Hospitals Enterprise LimitedHealthcare Services 5.3%
Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology 5.01%
Mankind Pharma LimitedPharmaceuticals & Biotechnology 3.74%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology 3.62%
Ajanta Pharma LimitedPharmaceuticals & Biotechnology 3.41%
Max Healthcare Institute LimitedHealthcare Services 3.15%
Top 10 57.34%Securities 35Securities total 97.32%Cash & equivalents 2.68%
The ten largest securities by weight, out of 35 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.

Risk

Volatility · annualised · 3Y
14.33%
Max drawdown · 3Y
-14.72%
Sharpe ratio
0.87
SEBI riskometer
Very High
Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed (as at 24 July 2026).
Beta and alpha are not shown. No benchmark series in the source.

Cost

Expense ratio1%
Category average1.73%
Exit load1%
52W high / low₹647.4211 / ₹539.2707
Expense ratio 1% vs a category average of 1.73% — 0.73 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 55th of 166, cheapest first.
Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.

Scheme facts

SEBI sub-category Sectoral/ Thematic
Plan / option Direct Growth
Benchmark BSE Health Care - TRI
Fund manager Sailesh Raj Bhan
Launched 10 May 2004
NAV history here 10.0y
ISIN INF204K01I50
AMFI scheme code 118759
SEBI riskometer Very High
Exit load 1%
Lock-in None
Minimum lumpsum ₹5,000
Exit load, as disclosed: 1% on or before 1M · Nil after 1M
Not shown on this page, and why
Star ratingGFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.
Scheme AUMScheme-level AUM is not in the source; only AMC-total AUM, which is a different number.
Minimum SIPNot present in the source.
Beta and alphaNo benchmark series in the source.

General SIP calculator

A general SIP illustration: your monthly amount grown at the annual rate you set below, compounded monthly. The rate is your assumption — it is not this scheme’s past return, not a forecast of it, and mutual fund returns are not assured.
Monthly SIP₹10,000
Tenure10 years
Assumed annual return12%
Invested₹12,00,000
Est. gain₹11,23,391
Total value₹23,23,391